Genesis Healthcare Inc is a medical care facilities business based in the US. Genesis Healthcare shares (GEN) are listed on the NYSE and all prices are listed in US Dollars. Genesis Healthcare employs 44,000 staff and has a trailing 12-month revenue of around USD$3.9 billion.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Since the stock market crash in March caused by coronavirus, Genesis Healthcare's stock price has had significant negative movement.
Its last market close was $0.2201, which is 87.28% down on its pre-crash value of $1.73 and 231.67% down on the lowest point reached during the March crash when the stocks fell as low as $0.73.
If you had bought $1,000 worth of Genesis Healthcare stocks at the start of February 2020, those stocks would have been worth $569.54 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $145.76.
|Latest market close||$0.22|
|52-week range||$0.18 - $1.18|
|50-day moving average||$0.57|
|200-day moving average||$0.58|
|Wall St. target price||$0.53|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.25|
Note: The dollar amounts in the table below are in Canadian dollars.
|1 week (2021-10-06)||N/A|
|1 month (2021-09-13)||N/A|
|3 months (2021-07-13)||N/A|
|6 months (2021-04-16)||19.68%|
|1 year (2020-10-16)||-56.84%|
|2 years (2019-10-16)||-84.05%|
|3 years (2018-10-16)||1.55|
|5 years (2016-10-14)||2.57|
Valuing Genesis Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genesis Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Genesis Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $160.9 million.
The EBITDA is a measure of a Genesis Healthcare's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$3.9 billion|
|Gross profit TTM||$1.7 billion|
|Return on assets TTM||-3.87%|
|Return on equity TTM||0%|
|Market capitalisation||$70.4 million|
TTM: trailing 12 months
There are currently 2.3 million Genesis Healthcare shares held short by investors – that's known as Genesis Healthcare's "short interest". This figure is 96% up from 1.2 million last month.
There are a few different ways that this level of interest in shorting Genesis Healthcare shares can be evaluated.
Genesis Healthcare's "short interest ratio" (SIR) is the quantity of Genesis Healthcare shares currently shorted divided by the average quantity of Genesis Healthcare shares traded daily (recently around 11.0 million). Genesis Healthcare's SIR currently stands at 0.21. In other words for every 100,000 Genesis Healthcare shares traded daily on the market, roughly 210 shares are currently held short.
However Genesis Healthcare's short interest can also be evaluated against the total number of Genesis Healthcare shares, or, against the total number of tradable Genesis Healthcare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Genesis Healthcare's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Genesis Healthcare shares in existence, roughly 10 shares are currently held short) or 0.0285% of the tradable shares (for every 100,000 tradable Genesis Healthcare shares, roughly 29 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Genesis Healthcare.
We're not expecting Genesis Healthcare to pay a dividend over the next 12 months.
Genesis Healthcare's shares were split on a 10:11 basis on 4 April 2013. So if you had owned 11 shares the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Genesis Healthcare shares – just the quantity. However, indirectly, the new 10% higher share price could have impacted the market appetite for Genesis Healthcare shares which in turn could have impacted Genesis Healthcare's share price.
Over the last 12 months, Genesis Healthcare's shares have ranged in value from as little as $0.1801 up to $1.18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Genesis Healthcare's is 1.364. This would suggest that Genesis Healthcare's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Genesis Healthcare, Inc. , together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc.
Stock trading doesn’t have to be expensive. Using Finder’s proprietary algorithm, we’ve identified the best cheap Canadian and US stocks to buy now.Read more…
Cue Health—developer of a COVID-19 self-testing kit with conditional approval in the US, Canada, European Union and India—has gone public. Here’s how to buy in.Read more…
Steps to owning and managing ARBK stock, with 24-hour and historical pricing before you buy.Read more…
Steps to owning and managing ITUB, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
Steps to owning and managing BSX stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing WM stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing MIN stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing LUC stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing GSV stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing FCU stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing AII stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing USA stock, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.